Poudel Pooja, Swe Thein, Rayancha Sheetal
State University of New York Upstate Medical University, Syracuse, NY, USA.
Interfaith Medical Center, New York, NY, USA.
J Investig Med High Impact Case Rep. 2018 Nov 15;6:2324709618812196. doi: 10.1177/2324709618812196. eCollection 2018 Jan-Dec.
Macrophage activation syndrome (MAS) itself is a rare, potentially life-threatening complication of a rheumatic disease, mostly seen in juvenile idiopathic arthritis. It infrequently occurs in systemic lupus erythematosus (SLE), and it is extremely rare to be the first presentation of SLE. In a study of 511 patients with SLE, 7 cases (1.4%) of MAS were identified. In all the cases, MAS was simultaneous to the presentation of SLE in this article, we report a case of a patient with MAS who presented with fever, rash, and high ferritin level up to 16911 ng/mL. A high degree of suspicion is required that high fever and rash can be clues to MAS. Early diagnosis is necessary since mortality rates remain high for untreated cases.
巨噬细胞活化综合征(MAS)本身是一种罕见的、可能危及生命的风湿性疾病并发症,多见于幼年特发性关节炎。它在系统性红斑狼疮(SLE)中很少发生,作为SLE的首发表现极为罕见。在一项对511例SLE患者的研究中,确诊了7例(1.4%)MAS。在本文所有病例中,MAS均与SLE同时出现,我们报告一例MAS患者,其表现为发热、皮疹,铁蛋白水平高达16911 ng/mL。对于高热和皮疹可能是MAS的线索需要高度怀疑。由于未治疗病例的死亡率仍然很高,因此早期诊断是必要的。